002092.SZ
Xinjiang Zhongtai Chemical Co., Ltd. [002092.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002092.SZ Stock Summary
Top 10 Correlated ETFs
002092.SZ
Top 10 Correlated Stocks
002092.SZ
In the News
002092.SZ Financial details
Company Rating
-
Market Cap
17.15B
Income
-50.19M
Revenue
51.61B
Book val./share
9.87
Cash/share
3.12
Dividend
0.1
Dividend %
1.52%
Employees
23.11K
Optionable
No
Shortable
Yes
Earnings
26 Oct 2023
P/E
-22.42
Forward P/E
28.57
PEG
2.02
P/S
0.46
P/B
0.66
P/C
2.11
P/FCF
-4.04
Quick Ratio
0.61
Current Ratio
0.75
Debt / Equity
0.87
LT Debt / Equity
0.41
-
-
EPS (TTM)
-0.13
EPS next Y
0.23
EPS next Q
-
EPS this Y
-76.27%
EPS next Y
-276.92%
EPS next 5Y
-276.92%
EPS last 5Y
-23.66%
Revenue last 5Y
-4.46%
Revenue Q/Q
-27.55%
EPS Q/Q
-
-
-
-
-
SMA20
1.84%
SMA50
-7.26%
SMA100
3.59%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-3%
ROC
-0.02%
Gross Margin
10%
Oper. Margin
-2%
Profit Margin
-2%
Payout
-99%
Shs Outstand
2.59B
Shs Float
1.69B
-
-
-
-
Target Price
-
52W Range
6.04-9.36
52W High
-27%
52W Low
+9.5%
RSI
44.74
Rel Volume
0.41
Avg Volume
22.77M
Volume
9.23M
Perf Week
-2.38%
Perf Month
1.39%
Perf Quarter
-7.2%
Perf Half Y
-2.67%
-
-
-
-
Beta
0.805
-
-
Volatility
0.04%, 0.17%
Prev Close
-0.76%
Price
6.57
Change
-0.45%
002092.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 31.31 | 38.72 | 39.21 | 26.86 | 21.71 | |
| Net income per share | 1.08 | 0.16 | 0.07 | 1.16 | 0.28 | |
| Operating cash flow per share | 2.85 | 3.82 | 3.29 | 1.92 | 2.07 | |
| Free cash flow per share | 0.95 | 1.57 | 2.37 | 1.21 | 0.01 | |
| Cash per share | 1.63 | 2.11 | 2.4 | 2.06 | 3.15 | |
| Book value per share | 8.44 | 8.8 | 8.78 | 10.85 | 9.99 | |
| Tangible book value per share | 8.47 | 9.74 | 9.58 | 12.76 | 12.11 | |
| Share holders equity per share | 8.44 | 8.8 | 8.78 | 10.85 | 9.99 | |
| Interest debt per share | 11.11 | 10.08 | 9.95 | 8.39 | 7.86 | |
| Market cap | 15.18B | 14.58B | 13.21B | 22.18B | 19.22B | |
| Enterprise value | 35.37B | 30.38B | 28.28B | 35.62B | 30.18B | |
| P/E ratio | 6.25 | 42.48 | 90.49 | 8.21 | 26.91 | |
| Price to sales ratio | 0.22 | 0.18 | 0.16 | 0.36 | 0.34 | |
| POCF ratio | 2.37 | 1.78 | 1.87 | 4.98 | 3.61 | |
| PFCF ratio | 7.11 | 4.31 | 2.6 | 7.9 | 698.22 | |
| P/B Ratio | 0.8 | 0.77 | 0.7 | 0.88 | 0.75 | |
| PTB ratio | 0.8 | 0.77 | 0.7 | 0.88 | 0.75 | |
| EV to sales | 0.5 | 0.37 | 0.34 | 0.57 | 0.54 | |
| Enterprise value over EBITDA | 6.04 | 8.41 | 8.5 | 4.83 | 5.68 | |
| EV to operating cash flow | 5.53 | 3.7 | 4.01 | 7.99 | 5.67 | |
| EV to free cash flow | 16.58 | 8.99 | 5.57 | 12.69 | 1.1K | |
| Earnings yield | 0.16 | 0.02 | 0.01 | 0.12 | 0.04 | |
| Free cash flow yield | 0.14 | 0.23 | 0.38 | 0.13 | 0 | |
| Debt to equity | 1.26 | 1.08 | 1.07 | 0.72 | 0.74 | |
| Debt to assets | 0.41 | 0.34 | 0.32 | 0.25 | 0.24 | |
| Net debt to EBITDA | 3.45 | 4.38 | 4.53 | 1.82 | 2.06 | |
| Current ratio | 0.76 | 0.69 | 0.65 | 0.75 | 0.7 | |
| Interest coverage | 2.78 | 0.31 | 0.17 | 2.75 | 1.22 | |
| Income quality | 2.5 | 42.86 | -163.63 | 1.48 | 4.86 | |
| Dividend Yield | 0.11 | 0.11 | 0.09 | 0.05 | 0.07 | |
| Payout ratio | 0.71 | 4.83 | 8.19 | 0.41 | 1.77 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0.01 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.67 | -0.59 | -0.28 | -0.37 | -0.99 | |
| Capex to revenue | -0.06 | -0.06 | -0.02 | -0.03 | -0.09 | |
| Capex to depreciation | -2.62 | -2.73 | -1.01 | -0.72 | -1.97 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 14.34 | 5.63 | 3.66 | 16.84 | 7.9 | |
| ROIC | 0.06 | 0 | 0 | 0.07 | 0.03 | |
| Return on tangible assets | 0.04 | 0.01 | 0 | 0.04 | 0.01 | |
| Graham Net | -10.44 | -11.41 | -12.49 | -10.47 | -11.27 | |
| Working capital | -6.83B | -8.48B | -11.09B | -7.63B | -10.07B | |
| Tangible asset value | 19.01B | 20.92B | 20.58B | 29.68B | 31.2B | |
| Net current asset value | -17.8B | -19.35B | -21.87B | -18.46B | -23.84B | |
| Invested capital | 1.26 | 1.08 | 1.07 | 0.72 | 0.74 | |
| Average receivables | 12.43B | 12.18B | 11.67B | 13.97B | 13.23B | |
| Average payables | 7.18B | 9.2B | 10.93B | 9.79B | 10.38B | |
| Average inventory | 2.79B | 2.96B | 2.51B | 2.33B | 3.13B | |
| Days sales outstanding | 72.18 | 46.02 | 55.76 | 88.1 | 74.25 | |
| Days payables outstanding | 45.49 | 50.11 | 51.64 | 56.73 | 92.32 | |
| Days of inventory on hand | 16.44 | 14.68 | 8.77 | 18.64 | 26.14 | |
| Receivables turnover | 5.06 | 7.93 | 6.55 | 4.14 | 4.92 | |
| Payables turnover | 8.02 | 7.28 | 7.07 | 6.43 | 3.95 | |
| Inventory turnover | 22.2 | 24.87 | 41.63 | 19.58 | 13.96 | |
| ROE | 0.13 | 0.02 | 0.01 | 0.11 | 0.03 | |
| Capex per share | -1.9 | -2.25 | -0.92 | -0.71 | -2.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.82 | 0 | 0 | 0 | 4.16 | |
| Net income per share | 0.17 | 0 | 0 | 0 | -0.13 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | -0.26 | 0 | 0 | 0 | -0.4 | |
| Cash per share | 2 | 0 | 0 | 0 | 3.12 | |
| Book value per share | 9.97 | 0 | 0 | 0 | 9.87 | |
| Tangible book value per share | 11.72 | 0 | 0 | 0 | 11.94 | |
| Share holders equity per share | 9.97 | 0 | 0 | 0 | 9.87 | |
| Interest debt per share | 7.69 | 0 | 0 | 0 | 8.63 | |
| Market cap | 23.26B | 0 | 0 | 0 | 18.67B | |
| Enterprise value | 37.63B | 11.79B | 12.85B | 10.96B | 32.62B | |
| P/E ratio | 13.15 | 0 | 0 | 0 | -14.5 | |
| Price to sales ratio | 1.55 | 0 | 0 | 0 | 1.74 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | -34.12 | 0 | 0 | 0 | -17.91 | |
| P/B Ratio | 0.91 | 0 | 0 | 0 | 0.73 | |
| PTB ratio | 0.91 | 0 | 0 | 0 | 0.73 | |
| EV to sales | 2.51 | 0.82 | 1.09 | 0.74 | 3.05 | |
| Enterprise value over EBITDA | 40.95 | 8.46 | 30.96 | -106.16 | -171.37 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | -55.19 | -8.14 | -8.79 | -6.42 | -31.29 | |
| Earnings yield | 0.02 | 0 | 0 | 0 | -0.02 | |
| Free cash flow yield | -0.03 | 0 | 0 | 0 | -0.06 | |
| Debt to equity | 0.76 | 0.72 | 0.78 | 0.74 | 0.87 | |
| Debt to assets | 0.25 | 0.24 | 0.25 | 0.24 | 0.27 | |
| Net debt to EBITDA | 15.63 | 8.46 | 30.96 | -106.16 | -73.3 | |
| Current ratio | 0.81 | 0.71 | 0.78 | 0.7 | 0.75 | |
| Interest coverage | 2.06 | 3.82 | 0.29 | -1.41 | -1.77 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0.01 | 0 | 0 | 0 | 0.01 | |
| Payout ratio | 0.55 | 0.76 | 30.82 | -0.44 | -0.8 | |
| Sales general and administrative to revenue | 0.02 | -0.02 | 0.08 | -0.05 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0.02 | 0.01 | 0 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | -0.05 | -0.1 | -0.12 | -0.12 | -0.1 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 6.21 | 0 | 0 | 0 | 5.27 | |
| ROIC | 0.01 | 0.02 | 0 | -0.01 | -0.01 | |
| Return on tangible assets | 0.01 | 0.01 | 0 | -0.01 | 0 | |
| Graham Net | -9.84 | 0 | 0 | 0 | -11.7 | |
| Working capital | -6.44B | -9.49B | -7.83B | -10.07B | -8.39B | |
| Tangible asset value | 30.18B | 31.13B | 31.23B | 31.2B | 30.75B | |
| Net current asset value | -18.48B | -21.62B | -22.23B | -23.84B | -24.31B | |
| Invested capital | 0.76 | 0.72 | 0.78 | 0.74 | 0.87 | |
| Average receivables | 16.35B | 14.99B | 13.85B | 13.35B | 12.04B | |
| Average payables | 9.23B | 11.31B | 12.75B | 12.69B | 11.99B | |
| Average inventory | 3B | 3.42B | 3.74B | 3.7B | 3.78B | |
| Days sales outstanding | 105.65 | 77.62 | 117.05 | 69.27 | 106.87 | |
| Days payables outstanding | 68.76 | 94.27 | 113.82 | 82.02 | 106.03 | |
| Days of inventory on hand | 22.1 | 27.12 | 34.07 | 23.22 | 37.12 | |
| Receivables turnover | 0.85 | 1.16 | 0.77 | 1.3 | 0.84 | |
| Payables turnover | 1.31 | 0.95 | 0.79 | 1.1 | 0.85 | |
| Inventory turnover | 4.07 | 3.32 | 2.64 | 3.88 | 2.42 | |
| ROE | 0.02 | 0.03 | 0 | -0.02 | -0.01 | |
| Capex per share | -0.26 | 0 | 0 | 0 | -0.4 |
002092.SZ Frequently Asked Questions
What is Xinjiang Zhongtai Chemical Co., Ltd. stock symbol ?
Xinjiang Zhongtai Chemical Co., Ltd. is a CN stock and trading under the symbol 002092.SZ
What is Xinjiang Zhongtai Chemical Co., Ltd. stock quote today ?
Xinjiang Zhongtai Chemical Co., Ltd. stock price is $6.57 today.
Is Xinjiang Zhongtai Chemical Co., Ltd. stock public?
Yes, Xinjiang Zhongtai Chemical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 22.77M
- Market Capitalization 17.15B
- Employee 23.11K
- CEO Mr. Jun Jiang
- Headquarters Ürümqi,CN
- IPO Date 2006-12-08
-
Website
https://www.zthx.com 
Xinjiang Zhongtai Chemical Co., Ltd. manufactures and sells chemicals under the Feng brand name in China. The company offers polyvinyl chloride products, ion-exchange membrane caustic soda, viscose fiber, viscose yarn, blue carbon, calcium carbide, and calcium carbide slag to make cement, cotton pulp, and other circular economy industrial chains. It also exports its products. The company was founded in 2011 and is based in Ürümqi, China.
